VitaNova Life Sciences (VNOV) Cash & Equivalents Growth (1y) (2018 - 2026)
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 5.54% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 59.56% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | -32.26% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | -24.05% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | -4.94% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | -21.99% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | -11.04% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 7.14% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 16.94% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 53.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 104.04% |
| Jan 31, 2026 | 188.50% |
| Oct 31, 2025 | 465.22% |
| Jul 31, 2025 | 638.96% |
| Apr 30, 2025 | 32.00% |
| Jan 31, 2025 | -49.88% |
| Apr 30, 2024 | 6,694.64% |
| Jan 31, 2024 | 7,240.02% |
| Apr 30, 2023 | -62.22% |
| Jan 31, 2023 | -70.18% |
| Oct 31, 2022 | 14.19% |
| Jan 31, 2019 | -89.73% |
| Oct 31, 2018 | -99.63% |
| Apr 30, 2018 | 2,056.59% |